Suchergebnisse - "Capobianco, Marco"

PubPharm (169)

1

COVID-19 outbreak in Italy : an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients

enthalten in: Journal of neurology | 2024

von Bisecco, A. | Matrone, F. | Capobianco, M. | +59

2

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2024

von Carta, S. | Dinoto, A. | Capobianco, M. | +24

3

Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

enthalten in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology | 2023

von Mosconi, P. | Guerra, T. | Paletta, P. | +114

4

Clinical relevance of thymic and bone marrow outputs in multiple sclerosis patients treated with alemtuzumab

enthalten in: Journal of neuroimmunology | 2023

von Sottini, A. | Quaresima, V. | Barbaro, M. | +23

5

Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants

enthalten in: Neurology | 2023

von Beretta, S. | Cristillo, V. | Camera, G. | +155

ErratumIn: Neurology. 2024 Feb 13;102(3):e208093. - PMID 38165306

6

Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease : Results from a Single-Center Study

enthalten in: Neurology and therapy | 2023

von Bruschi, N. | Malentacchi, M. | Malucchi, S. | +7

7

Sars-CoV2 infection in pregnant women with multiple sclerosis

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2023

von Aprea, M. | Schiavetti, I. | Portaccio, E. | +53

8

Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

enthalten in: Neurological sciences | 2023

von Mosconi, P. | Guerra, T. | Paletta, P. | +13

9

Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study

enthalten in: Neurology and Therapy | 2023

von Bruschi, N. | Malentacchi, M. | Malucchi, S. | +7

10

Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study

enthalten in: Neurology and Therapy | 2023

von Bruschi, N. | Malentacchi, M. | Malucchi, S. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]